1. AstraZeneca breast cancer treatment gets FDA priority review
Reuters) - AstraZeneca Plc said on Thursday that the U.S. drug regulator will give a speedy review to its experimental breast cancer treatment, which could put the British drugmaker in direct competition with bigger rival Roche Holding AG. The U.S. Food and Drug Administration (FDA) accepted AstraZeneca’s application and granted the treatment, trastuzumab deruxtecan, a priority review for the treatment of HER2-positive metastatic breast cancer, the drugmaker said.more details...


2. 11 Signs of Breast Cancer Every Woman Should Know About
Your girls do a lot for you—deliver confidence, feed your offspring, enhance pleasure. The least you can do for them is to be aware when something is awry—that is, know the first signs of breast cancer. Roughly one in eight women develop invasive breast cancer in their lifetime and it's the second most commonly-diagnosed cancer among women in the U.S., according to the American Cancer Society.more details...